Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard G Gower

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Allergy and Asthma Proceedings|February 15, 2013
HAE update: determining optimal patient specific therapyRichard G Gower
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|October 10, 2021
Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedemaRichard G Gower, Mary Wilber
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 14, 2023
Challenges in the management of hereditary angioedema in urban and rural settings: Results of a United States surveyJ Allen Meadows, John Anderson, Richard G Gower
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2011
Current medical management of hereditary angioedema: results from a large survey of US physiciansMarc Riedl, Richard G Gower, Carole Alison Chrvala
Allergy and Asthma Proceedings|May 16, 2012
Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerationsRichard G Gower, William R Lumry, Mark A Davis-Lorton, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 5, 2009
When is prophylaxis for hereditary angioedema necessary?Timothy Craig, Marc Riedl, Mark S Dykewicz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 30, 2018
Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiencyTimothy Craig, Paula Busse, Richard G Gower, et al.
American Journal of Clinical Dermatology|May 15, 2023
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical StudyLawrence F Eichenfield, Richard G Gower, JinHua Xu, et al.
The World Allergy Organization Journal|January 4, 2013
Hereditary angioedema caused by c1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategiesRichard G Gower, Paula J Busse, Emel Aygören-Pürsün, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedemaJonathan A Bernstein, Michael E Manning, Henry Li, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Allergy and Asthma Proceedings|February 15, 2013
HAE update: determining optimal patient specific therapyRichard G Gower
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|October 10, 2021
Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedemaRichard G Gower, Mary Wilber
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 14, 2023
Challenges in the management of hereditary angioedema in urban and rural settings: Results of a United States surveyJ Allen Meadows, John Anderson, Richard G Gower
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2011
Current medical management of hereditary angioedema: results from a large survey of US physiciansMarc Riedl, Richard G Gower, Carole Alison Chrvala
Allergy and Asthma Proceedings|May 16, 2012
Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerationsRichard G Gower, William R Lumry, Mark A Davis-Lorton, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 5, 2009
When is prophylaxis for hereditary angioedema necessary?Timothy Craig, Marc Riedl, Mark S Dykewicz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 30, 2018
Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiencyTimothy Craig, Paula Busse, Richard G Gower, et al.
American Journal of Clinical Dermatology|May 15, 2023
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical StudyLawrence F Eichenfield, Richard G Gower, JinHua Xu, et al.
The World Allergy Organization Journal|January 4, 2013
Hereditary angioedema caused by c1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategiesRichard G Gower, Paula J Busse, Emel Aygören-Pürsün, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedemaJonathan A Bernstein, Michael E Manning, Henry Li, et al.
Pageof 2